(Q46783489)

25 December 2017

title

Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database (English)

1 reference

25 December 2017

Hirotaka Watada

6

0 references

Wladyslaw Grzeszczak

object named as

Wladyslaw Grzeszczak

5

0 references

Sanjay Kalra

8

object named as

Sanjay Kalra

1 reference

25 December 2017

author name string

Jianping Weng

1

1 reference

25 December 2017

Sidartawan Soegondo

2

1 reference

25 December 2017

Oliver Schnell

3

1 reference

25 December 2017

Wayne H-H Sheu

4

1 reference

25 December 2017

Noriyuki Yamamoto

7

1 reference

25 December 2017

publication date

12 October 2014

1 reference

25 December 2017

Diabetes - Metabolism: Research and Reviews

published in

1 reference

25 December 2017

volume

31

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

155-167

1 reference

25 December 2017

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

cites work

1 reference

α-Glucosidase inhibitors and their use in clinical practice

21 January 2018

1 reference

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations

21 January 2018

1 reference

Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation

21 January 2018

1 reference

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

21 January 2018

1 reference

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

21 January 2018

1 reference

Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.

21 January 2018

1 reference

Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: an Asian-Pacific perspective and expert recommendations

21 January 2018

1 reference

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

21 January 2018

1 reference

Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study

21 January 2018

1 reference

An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group

21 January 2018

1 reference

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes.

21 January 2018

1 reference

Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study.

21 January 2018

1 reference

Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin

21 January 2018

1 reference

Acarbose in ambulatory treatment of non-insulin-dependent diabetes mellitus associated to imminent sulfonylurea failure: a randomised-multicentric trial in primary health-care. Diabetes and Acarbose Research Group.

21 January 2018

1 reference

Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas

21 January 2018

1 reference

Long-term improvement of metabolic control by acarbose in type 2 diabetes patients poorly controlled with maximum sulfonylurea therapy.

21 January 2018

1 reference

Long-term efficacy and tolerability of acarbose treatment in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study

21 January 2018

1 reference

Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes.

21 January 2018

1 reference

Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison

21 January 2018

1 reference

Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China.

21 January 2018

1 reference

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis

21 January 2018

1 reference

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

21 January 2018

1 reference

Comparison of the hypoglycemic effect of acarbose monotherapy in patients with type 2 diabetes mellitus consuming an Eastern or Western diet: a systematic meta-analysis

21 January 2018

1 reference

Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian

21 January 2018

1 reference

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

21 January 2018

1 reference

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

21 January 2018

1 reference

White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review

21 January 2018

1 reference

South Asian diets and insulin resistance

21 January 2018

1 reference

Glycaemic index of common foods tested in the UK and India

21 January 2018

1 reference

Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes

21 January 2018

1 reference

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

21 January 2018

1 reference

India at the cross-roads of human evolution

21 January 2018

1 reference

Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals.

21 January 2018

1 reference

Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes

21 January 2018

1 reference

Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs

21 January 2018

1 reference

Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitus

21 January 2018

1 reference

Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis

21 January 2018

1 reference

Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus : a postmarketing surveillance study

21 January 2018

1 reference

International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus

21 January 2018

1 reference

A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study

21 January 2018

1 reference

Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus.

21 January 2018

1 reference

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

21 January 2018

1 reference

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

Recommendations for insulin initiation based on ethnicity

21 January 2018

1 reference

AACE comprehensive diabetes management algorithm 2013.

21 January 2018

1 reference

7 January 2021

Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study

1 reference

7 January 2021

An importance of carbohydrate ingestion for the expression of the effect of alpha-glucosidase inhibitor in NIDDM

1 reference

7 January 2021

Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.2576

1 reference

25 December 2017

PubMed ID

25044702

1 reference

25 December 2017